Subcutaneous Biologics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Subcutaneous Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Subcutaneous Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Subcutaneous Biologics Overall Market Size
2.1 Global Subcutaneous Biologics Market Size: 2022 VS 2029
2.2 Global Subcutaneous Biologics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Subcutaneous Biologics Players in Global Market
3.2 Top Global Subcutaneous Biologics Companies Ranked by Revenue
3.3 Global Subcutaneous Biologics Revenue by Companies
3.4 Top 3 and Top 5 Subcutaneous Biologics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Subcutaneous Biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Subcutaneous Biologics Players in Global Market
3.6.1 List of Global Tier 1 Subcutaneous Biologics Companies
3.6.2 List of Global Tier 2 and Tier 3 Subcutaneous Biologics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Subcutaneous Biologics Market Size Markets, 2022 & 2029
4.1.2 Syringe
4.1.3 Wearable injector
4.1.4 Automatic injector
4.1.5 Implants
4.2 By Type - Global Subcutaneous Biologics Revenue & Forecasts
4.2.1 By Type - Global Subcutaneous Biologics Revenue, 2018-2023
4.2.2 By Type - Global Subcutaneous Biologics Revenue, 2024-2029
4.2.3 By Type - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Subcutaneous Biologics Market Size, 2022 & 2029
5.1.2 Hospital pharmacies
5.1.3 Retail pharmacies
5.1.4 Drug stores
5.1.5 Online pharmacies
5.2 By Application - Global Subcutaneous Biologics Revenue & Forecasts
5.2.1 By Application - Global Subcutaneous Biologics Revenue, 2018-2023
5.2.2 By Application - Global Subcutaneous Biologics Revenue, 2024-2029
5.2.3 By Application - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Subcutaneous Biologics Market Size, 2022 & 2029
6.2 By Region - Global Subcutaneous Biologics Revenue & Forecasts
6.2.1 By Region - Global Subcutaneous Biologics Revenue, 2018-2023
6.2.2 By Region - Global Subcutaneous Biologics Revenue, 2024-2029
6.2.3 By Region - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Subcutaneous Biologics Revenue, 2018-2029
6.3.2 US Subcutaneous Biologics Market Size, 2018-2029
6.3.3 Canada Subcutaneous Biologics Market Size, 2018-2029
6.3.4 Mexico Subcutaneous Biologics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Subcutaneous Biologics Revenue, 2018-2029
6.4.2 Germany Subcutaneous Biologics Market Size, 2018-2029
6.4.3 France Subcutaneous Biologics Market Size, 2018-2029
6.4.4 U.K. Subcutaneous Biologics Market Size, 2018-2029
6.4.5 Italy Subcutaneous Biologics Market Size, 2018-2029
6.4.6 Russia Subcutaneous Biologics Market Size, 2018-2029
6.4.7 Nordic Countries Subcutaneous Biologics Market Size, 2018-2029
6.4.8 Benelux Subcutaneous Biologics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Subcutaneous Biologics Revenue, 2018-2029
6.5.2 China Subcutaneous Biologics Market Size, 2018-2029
6.5.3 Japan Subcutaneous Biologics Market Size, 2018-2029
6.5.4 South Korea Subcutaneous Biologics Market Size, 2018-2029
6.5.5 Southeast Asia Subcutaneous Biologics Market Size, 2018-2029
6.5.6 India Subcutaneous Biologics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Subcutaneous Biologics Revenue, 2018-2029
6.6.2 Brazil Subcutaneous Biologics Market Size, 2018-2029
6.6.3 Argentina Subcutaneous Biologics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Subcutaneous Biologics Revenue, 2018-2029
6.7.2 Turkey Subcutaneous Biologics Market Size, 2018-2029
6.7.3 Israel Subcutaneous Biologics Market Size, 2018-2029
6.7.4 Saudi Arabia Subcutaneous Biologics Market Size, 2018-2029
6.7.5 UAE Subcutaneous Biologics Market Size, 2018-2029
7 Subcutaneous Biologics Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Subcutaneous Biologics Major Product Offerings
7.1.4 Abbott Laboratories Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Subcutaneous Biologics Major Product Offerings
7.2.4 Pfizer Inc. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Genentech Inc.
7.3.1 Genentech Inc. Company Summary
7.3.2 Genentech Inc. Business Overview
7.3.3 Genentech Inc. Subcutaneous Biologics Major Product Offerings
7.3.4 Genentech Inc. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.3.5 Genentech Inc. Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Subcutaneous Biologics Major Product Offerings
7.4.4 Novartis AG Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Biogen Idec
7.5.1 Biogen Idec Company Summary
7.5.2 Biogen Idec Business Overview
7.5.3 Biogen Idec Subcutaneous Biologics Major Product Offerings
7.5.4 Biogen Idec Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.5.5 Biogen Idec Key News & Latest Developments
7.6 AbbVie Inc.
7.6.1 AbbVie Inc. Company Summary
7.6.2 AbbVie Inc. Business Overview
7.6.3 AbbVie Inc. Subcutaneous Biologics Major Product Offerings
7.6.4 AbbVie Inc. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.6.5 AbbVie Inc. Key News & Latest Developments
7.7 F. Hoffmann-La Roche AG
7.7.1 F. Hoffmann-La Roche AG Company Summary
7.7.2 F. Hoffmann-La Roche AG Business Overview
7.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Major Product Offerings
7.7.4 F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.7.5 F. Hoffmann-La Roche AG Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Subcutaneous Biologics Major Product Offerings
7.8.4 Bristol-Myers Squibb Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Eisai Inc.
7.9.1 Eisai Inc. Company Summary
7.9.2 Eisai Inc. Business Overview
7.9.3 Eisai Inc. Subcutaneous Biologics Major Product Offerings
7.9.4 Eisai Inc. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.9.5 Eisai Inc. Key News & Latest Developments
7.10 Takeda Pharmaceuticals Ltd.
7.10.1 Takeda Pharmaceuticals Ltd. Company Summary
7.10.2 Takeda Pharmaceuticals Ltd. Business Overview
7.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Major Product Offerings
7.10.4 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.10.5 Takeda Pharmaceuticals Ltd. Key News & Latest Developments
7.11 Alnylam Pharmaceuticals
7.11.1 Alnylam Pharmaceuticals Company Summary
7.11.2 Alnylam Pharmaceuticals Business Overview
7.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Major Product Offerings
7.11.4 Alnylam Pharmaceuticals Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.11.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.12 Bayer AG
7.12.1 Bayer AG Company Summary
7.12.2 Bayer AG Business Overview
7.12.3 Bayer AG Subcutaneous Biologics Major Product Offerings
7.12.4 Bayer AG Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.12.5 Bayer AG Key News & Latest Developments
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Company Summary
7.13.2 GlaxoSmithKline Business Overview
7.13.3 GlaxoSmithKline Subcutaneous Biologics Major Product Offerings
7.13.4 GlaxoSmithKline Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.13.5 GlaxoSmithKline Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Subcutaneous Biologics Market Opportunities & Trends in Global Market
Table 2. Subcutaneous Biologics Market Drivers in Global Market
Table 3. Subcutaneous Biologics Market Restraints in Global Market
Table 4. Key Players of Subcutaneous Biologics in Global Market
Table 5. Top Subcutaneous Biologics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Subcutaneous Biologics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Subcutaneous Biologics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Subcutaneous Biologics Product Type
Table 9. List of Global Tier 1 Subcutaneous Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Subcutaneous Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Subcutaneous Biologics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Subcutaneous Biologics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Subcutaneous Biologics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Subcutaneous Biologics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Subcutaneous Biologics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Subcutaneous Biologics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Subcutaneous Biologics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Subcutaneous Biologics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Subcutaneous Biologics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Subcutaneous Biologics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Subcutaneous Biologics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Subcutaneous Biologics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Subcutaneous Biologics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Subcutaneous Biologics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Subcutaneous Biologics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Subcutaneous Biologics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Subcutaneous Biologics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Subcutaneous Biologics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Subcutaneous Biologics Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Subcutaneous Biologics Product Offerings
Table 32. Abbott Laboratories Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Pfizer Inc. Company Summary
Table 35. Pfizer Inc. Subcutaneous Biologics Product Offerings
Table 36. Pfizer Inc. Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Inc. Key News & Latest Developments
Table 38. Genentech Inc. Company Summary
Table 39. Genentech Inc. Subcutaneous Biologics Product Offerings
Table 40. Genentech Inc. Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 41. Genentech Inc. Key News & Latest Developments
Table 42. Novartis AG Company Summary
Table 43. Novartis AG Subcutaneous Biologics Product Offerings
Table 44. Novartis AG Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis AG Key News & Latest Developments
Table 46. Biogen Idec Company Summary
Table 47. Biogen Idec Subcutaneous Biologics Product Offerings
Table 48. Biogen Idec Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 49. Biogen Idec Key News & Latest Developments
Table 50. AbbVie Inc. Company Summary
Table 51. AbbVie Inc. Subcutaneous Biologics Product Offerings
Table 52. AbbVie Inc. Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 53. AbbVie Inc. Key News & Latest Developments
Table 54. F. Hoffmann-La Roche AG Company Summary
Table 55. F. Hoffmann-La Roche AG Subcutaneous Biologics Product Offerings
Table 56. F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 57. F. Hoffmann-La Roche AG Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Subcutaneous Biologics Product Offerings
Table 60. Bristol-Myers Squibb Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. Eisai Inc. Company Summary
Table 63. Eisai Inc. Subcutaneous Biologics Product Offerings
Table 64. Eisai Inc. Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 65. Eisai Inc. Key News & Latest Developments
Table 66. Takeda Pharmaceuticals Ltd. Company Summary
Table 67. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Offerings
Table 68. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda Pharmaceuticals Ltd. Key News & Latest Developments
Table 70. Alnylam Pharmaceuticals Company Summary
Table 71. Alnylam Pharmaceuticals Subcutaneous Biologics Product Offerings
Table 72. Alnylam Pharmaceuticals Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 73. Alnylam Pharmaceuticals Key News & Latest Developments
Table 74. Bayer AG Company Summary
Table 75. Bayer AG Subcutaneous Biologics Product Offerings
Table 76. Bayer AG Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 77. Bayer AG Key News & Latest Developments
Table 78. GlaxoSmithKline Company Summary
Table 79. GlaxoSmithKline Subcutaneous Biologics Product Offerings
Table 80. GlaxoSmithKline Subcutaneous Biologics Revenue (US$, Mn) & (2018-2023)
Table 81. GlaxoSmithKline Key News & Latest Developments
List of Figures
Figure 1. Subcutaneous Biologics Segment by Type in 2022
Figure 2. Subcutaneous Biologics Segment by Application in 2022
Figure 3. Global Subcutaneous Biologics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Subcutaneous Biologics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Subcutaneous Biologics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Subcutaneous Biologics Revenue in 2022
Figure 8. By Type - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Subcutaneous Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Subcutaneous Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 16. US Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 20. Germany Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 21. France Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 28. China Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 32. India Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 34. Brazil Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Subcutaneous Biologics Revenue Market Share, 2018-2029
Figure 37. Turkey Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Subcutaneous Biologics Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Inc. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Genentech Inc. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis AG Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Biogen Idec Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AbbVie Inc. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol-Myers Squibb Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Eisai Inc. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Alnylam Pharmaceuticals Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bayer AG Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. GlaxoSmithKline Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
